Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-07

Clinical Trial Update: 30-Day Trial of Oral Valtrex or Valtrex Plus Aspirin on Shedding of HSV DNA in Tears and Saliva of Volunteers [Phase 1]

View source ↗

Summary

This is a 30-day Phase 1 trial evaluating valacyclovir (Valtrex) alone or with aspirin. The study assesses shedding of herpes simplex virus DNA in tears and sal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Aspirin (Aspirin)
  • VALTREX (valacyclovir hydrochloride)

Snippet

Sponsor: National Eye Institute (NEI) | Conditions: Herpes Simplex | Phase 1 | Status: UNKNOWN